← Evidence map

ArticleMicrobiology spectrum2023

Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome.

Ryan Marsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37607068